Lapaquistat Acetate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLapaquistat Acetate
Drug Alias Name拉帕司他拉奎司他T-91485TAK-475
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSqualene synthase inhibitors
TargetsSqualene synthase
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemiasDyslipidemias +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[25
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaHyperlipidemiasDyslipidemias +[4

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG